EUVIMEDEUVIMED entdecken
Crossref

Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation

Ziliang He, Yeye Hu, Ying Zhang, Jing Xie, Zhiqiang Niu, Guigui Yang, Ji Zhang, Zixuan Zhao, Shuai Wei, Haifeng Wu, Weicheng Hu

Phytomedicine · 2024-05 · 127 · 155494

DOI: 10.1016/j.phymed.2024.155494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-05. Verfasst von Ziliang He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou 225009, China. Hauptthemen laut MEDLINE: MPTP Poisoning, Parkinson Disease, Neuroprotective Agents, Triterpenes. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, Chinese Academy of Meteorological Sciences, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Parkinson's disease (PD), a neurodegenerative disorder, is characterized by motor symptoms due to the progressive loss of dopaminergic neurons in the substantia nigra (SN) and striatum (STR), alongside neuroinflammation. Asiaticoside (AS), a primary active component with anti-inflammatory and neuroprotective properties, is derived from Centella asiatica. However, the precise mechanisms through which AS influences PD associated with inflammation are not yet fully understood. PURPOSE: This study aimed to explore the protective mechanism of AS in PD. METHODS: Targets associated with AS and PD were identified from the Swiss Target Prediction, Similarity Ensemble Approach, PharmMapper, and GeneCards database. A protein-protein interaction (PPI) network was constructed to identify potential therapeutic targets. Concurrently, GO and KEGG analyses were performed to predict potential signaling pathways. To validate these mechanisms, the effects of AS on 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD in mice were investigated. Furthermore, neuroinflammation and the activation of the NLRP3 inflammasome were assessed to confirm the anti-inflammatory properties of AS. In vitro experiments in BV2 cells were then performed to investigate the mechanisms of AS in PD. Moreover, CETSA, molecular docking, and molecular dynamics simulations (MDs) were performed for further validation. RESULTS: Network pharmacology analysis identified 17 potential targets affected by AS in PD. GO and KEGG analyses suggested the biological roles of these targets, demonstrating that AS interacts with 149 pathways in PD. Notably, the NOD-like receptor signaling pathway was identified as a key pathway mediating AS's effect on PD. In vivo studies demonstrated that AS alleviated motor dysfunction and reduced the loss of dopaminergic neurons in MPTP-induced PD mice. In vitro experiments demonstrated that AS substantially decreased IL-1β release in BV2 cells, attributing this to the modulation of the NLRP3 signaling pathway. CETSA and molecular docking studies indicated that AS forms a stable complex with NLRP3. MDs suggested that ARG578 played an important role in the formation of the complex. CONCLUSION: In this study, we first predicted that the potential target and pathway of AS's effect on PD could be NLRP3 protein and NOD-like receptor signaling pathway by network pharmacology analysis. Further, we demonstrated that AS could alleviate symptoms of PD induced by MPTP through its interaction with the NLRP3 protein for the first time by in vivo and in vitro experiments. By binding to NLRP3, AS effectively inhibits the assembly and activation of the inflammasome. These findings suggest that AS is a promising inhibitor for PD driven by NLRP3 overactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MPTP PoisoningParkinson DiseaseNeuroprotective AgentsTriterpenesMiceAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNeuroprotectionNeuroinflammatory DiseasesMolecular Docking SimulationMicrogliaDopaminergic NeuronsAnti-Inflammatory AgentsMice, Inbred C57BLDisease Models, Animal1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Stichwörter der Autor:innen

AsiaticosideNLRP3Network pharmacologyParkinson's disease

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinasiaticosideAnti-Inflammatory Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuroprotective AgentsTriterpenes

Autor:innen und Institutionen

  • Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou 225009, China.
  • School of Life Sciences, Huaiyin Normal University, Huaian 223300, China.
  • Beijing Key Laboratory of New Drug Discovery based on Classic Chinese Medicine Prescription, Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute…
  • College of Food Science and Technology, Guangdong Ocean University, Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products,…
  • Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou 225009, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile…

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • Chinese Academy of Meteorological Sciences
  • China Scholarship Council

Zitieren

APA

He, Z., Hu, Y., Zhang, Y., Xie, J., Niu, Z., Yang, G., Zhang, J., Zhao, Z., Wei, S., Wu, H., & Hu, W. (2024). Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. Phytomedicine, 127, 155494. https://doi.org/10.1016/j.phymed.2024.155494

Vancouver

He Z, Hu Y, Zhang Y, Xie J, Niu Z, Yang G, et al. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. Phytomedicine. 2024;127:155494. doi:10.1016/j.phymed.2024.155494

BibTeX
@article{He2024,
  author = {He, Ziliang and Hu, Yeye and Zhang, Ying and Xie, Jing and Niu, Zhiqiang and Yang, Guigui and Zhang, Ji and Zhao, Zixuan and Wei, Shuai and Wu, Haifeng and Hu, Weicheng},
  title = {Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation},
  journal = {Phytomedicine},
  year = {2024},
  volume = {127},
  pages = {155494},
  doi = {10.1016/j.phymed.2024.155494}
}
Kostenlos starten →